Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | LPO | P22079 | 1/20 | 0.43 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TRPM5 | Q9NZQ8 | 1/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.33 |
| ▸ | NAMPT | P43490 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2395476 | 1.00 | FDPS (0.44) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL2393253 | 1.00 | FDPS (0.44) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL7152443 | 1.00 | FDPS (0.44) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL7166348 | 0.98 | FDPS (0.46) | FDPSKMT2AMEN1LPOFNTA | |
| Water SCHEMBL29120398 | 0.95 | FDPS (0.44) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL2398203 | 0.93 | FDPS (0.46) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL301893 | 0.92 | TLR8 (0.44) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL1898631 | 0.92 | TLR8 (0.44) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL4240295 | 0.92 | TLR8 (0.44) | FDPSKMT2AMEN1LPOFNTA | |
| SCHEMBL2229133 | 0.92 | TLR8 (0.44) | FDPSKMT2AMEN1LPOFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3272740-A2 | HIGH STABILITY DIIONIC LIQUID SALTS | Sigma-Aldrich Co. LLC (US) | 2018-01-24 | — | — | EP | disclosed |
| US-9782746-B2 | Polymeric ionic liquids, methods of making and methods of use thereof | THE UNIVERSITY OF TOLEDO (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160114309-A1 | Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | THE UNIVERSITY OF TOLEDO (US) | 2016-04-28 | — | — | US | disclosed |
| US-9249261-B2 | Polymeric ionic liquids, methods of making and methods of use thereof | THE UNIVERSITY OF TOLEDO (US) | 2016-02-02 | — | — | US | disclosed |
| US-8956445-B2 | High stability diionic liquid salts | SIGMA-ALDRICH CO. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8734673-B2 | Boron selective ionic liquids and polymeric ionic liquids, methods of making and methods of use thereof | THE UNIVERSITY OF TOLEDO (US) | 2014-05-27 | — | — | US | disclosed |
| US-20140121387-A1 | High Stability Diionic Liquid Salts | SIGMA-ALDRICH CO. LLC (US) | 2014-05-01 | — | — | US | disclosed |
| EP-2682396-A1 | High stability diionic liquid salts | Sigma-Aldrich Co. (US) | 2014-01-08 | — | — | EP | disclosed |
| US-20120215005-A1 | High Stability Diionic Liquid Salts | SIGMA-ALDRICH CO. LLC (US) | 2012-08-23 | — | — | US | disclosed |
| US-20120211696-A1 | HIGH STABILITY DIIONIC LIQUID SALTS | SIGMA-ALDRICH CO. LLC (US) | 2012-08-23 | — | — | US | disclosed |
| US-8182581-B2 | use of these novel bis-cationic and/or bis-anionic ionic liquids as the stationary phase in a gas chromatographic column | SIGMA-ALDRICH CO. LLC (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120111796-A1 | Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | UNIVERSITY OF TOLEDO (US) | 2012-05-10 | — | — | US | disclosed |
| US-8168830-B2 | use of these novel ionic liquids having bis-cation or bis-anion separated by bridging group as the stationary phase in a gas chromatographic column | SIGMA-ALDRICH CO. LLC (US) | 2012-05-01 | — | — | US | disclosed |
| US-20110236295-A1 | Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | UNIVERSITY OF TOLEDO (US) | 2011-09-29 | — | — | US | disclosed |
| WO-2010017564-A1 | BORON SELECTIVE IONIC LIQUIDS AND POLYMERIC IONIC LIQUIDS, METHODS OF MAKING AND METHODS OF USE THEREOF | UNIVERSITY OF TOLEDO (US) | 2010-02-11 | — | — | WO | disclosed |
| WO-2010017563-A1 | POLYMERIC IONIC LIQUIDS, METHODS OF MAKING AND METHODS OF USE THEREOF | UNIVERSITY OF TOLEDO (US) | 2010-02-11 | — | — | WO | disclosed |
| US-20080027231-A1 | High stability diionic liquid salts | SIGMA-ALDRICH CO. (US) | 2008-01-31 | — | — | US | disclosed |
| US-20060025598-A1 | High stability diionic liquid salts | ADVANCED SEPARATION TECHNOLOGIES INC. (US) | 2006-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027231-A1 | High stability diionic liquid salts | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDHD5, DAD1 | FDPS 546/4885KMT2A 3995/4885MEN1 3166/4885 |
| US-20060025598-A1 | High stability diionic liquid salts | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DCLK2, HDHD5 | FDPS 577/4885KMT2A 3946/4885MEN1 3052/4885 |
| US-20120111796-A1 | Boron Selective Ionic Liquids and Polymeric Ionic Liquids, Methods of Making and Methods of Use Thereof | BCCIP, SLC6A12, BOLA2; BOLA2B | FDPS 2938/4885KMT2A 3451/4885MEN1 1196/4885 |
| US-20140121387-A1 | High Stability Diionic Liquid Salts | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DCLK2, HDHD5 | FDPS 577/4885KMT2A 3946/4885MEN1 3052/4885 |
| US-20120215005-A1 | High Stability Diionic Liquid Salts | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DCLK2, HDHD5 | FDPS 577/4885KMT2A 3946/4885MEN1 3052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.